Clinical Trial Details

EORTC-1208-MG

Back to Clinical Trials Database

Minitub: Prospective registry on Sentinel Node (SN) positive melanoma patients with minimal SN tumor burden who undergo Completion Lymph Node Dissections (CLND) or Nodal Observation.

Study documentation

Trial Status Closed to Patient Entry
Dates Date of activation: 28-Apr-2015
Date Step1 close: 02-Dec-2021
Data management at EORTC Yes
Design Cohort
Not randomized / N.A.
Targeted Sample size EORTC Groups: 260 - All Groups: 260
Treatment
Study Staff Alexander van Akkooi (Study Coordinator) , Melanoma Institute Australia -The Poche center, Wollstonecraft
Katrien Baus (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Tuula Ikonen (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Sven Janssen (Data Manager) , EORTC Headquarters, Brussels
Michal Kicinski (Statistician) , EORTC Headquarters, Brussels
Stephanie Kromar (Senior Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Robby Louis (Data Manager) , EORTC Headquarters, Brussels
Sandrine Marreaud (Clinical Research Physician) , EORTC Headquarters, Brussels
Anja Mestnik (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Zara Nasir (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Gaetan de Schaetzen (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels
Type of cancer Melanoma
Participating groups EORTC Melanoma Group
Recruiting centers CHRU de Lille (LILLE CEDEX, France)
CHU Amiens Picardie - Site Sud (Amiens, France)
CHU de Nice - Hopital De L'Archet (NICE, France)
Cambridge University Hospital NHS - Addenbrookes Hospital (Cambridge, United Kingdom)
Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland)
Erasmus MC (Rotterdam, Netherlands)
Gustave Roussy (VILLEJUIF CEDEX, France)
Guy's and St Thomas' NHS - St Thomas Hospital (London, United Kingdom)
Hospital Clinic de Barcelona (Barcelona, Spain)
IRCCS - Fondazione G. Pascale (Napoli, Italy)
IRCCS - Istituto Oncologico Veneto (Padova, Italy)
Istituto Europeo di Oncologia (Milano, Italy)
Leeds Teaching Hospitals NHS Trust - St. James's University Hospital (Leeds, United Kingdom)
Maria Sklodowska-Curie National Research Institute of Oncology (Warsaw, Poland)
Norfolk And Norwich Hospital (Norwich, United Kingdom)
St George's University Hospital NHS Trust Foundation (London, United Kingdom)
St George's University Hospital NHS Trust Foundation (London, United Kingdom)
St Helens & Knowsley NHS Trust - Whiston Hospital (Prescot - Merseyside, United Kingdom)
The Institute Of Oncology (Ljubljana, Slovenia)
The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis (Amsterdam, Netherlands)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
UniversitaetsMedizin Mannheim (Mannheim, Germany)
Universitaetsklinikum - Essen (Essen, Germany)
Universitaetsklinikum Heidelberg - Frauenklinik / Hautklinik (Heidelberg, Germany)
University Hospital Dorset : The Royal Bournemouth Hospital (Dorset, United Kingdom)
Protocol summary http://clinicaltrials.gov/study/NCT01942603
NCT number NCT01942603
Financial Support EORTC Group